Filing Details

Accession Number:
0001439222-24-000146
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-12-13 16:04:41
Reporting Period:
2024-12-11
Accepted Time:
2024-12-13 16:04:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1439222 Agios Pharmaceuticals Inc. AGIO Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1707715 David Scadden C/O Agios Pharmaceuticals, Inc.
88 Sidney Street
Cambridge MA 02139
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-12-11 200 $18.09 15,683 No 4 M Direct
Common Stock Disposition 2024-12-11 200 $46.28 15,483 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock options (right to buy) Disposition 2024-12-11 200 $0.00 200 $18.09
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
29,107 2032-06-21 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. This option was granted on June 21, 2022. The shares underlying this option vest 100% one year from grant date.